Skip to content

The clinical study on treating acute gouty arthritis using both internal and external therapy of tonifying spleen and descending turbid

The clinical study on treating acute gouty arthritis using both internal and external therapy of tonifying spleen and descending turbid

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-ICR-15006783
Enrollment
Unknown
Registered
2015-07-21
Start date
2014-12-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute gouty arthritis

Interventions

Treatment Group:Take oral medicine of tonifying spleen and descending turbid
Treatment Group:The onset of the joints afford steeping washing medicine of descending turbid and clearing heat
Treatment Group:The onset of the joints afford wet wrapping medicine of descending turbid and clearing heat
Control Group:Take diclofenac sodium enteric-coated

Sponsors

Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Aged 18-75, and gender unlimited; (2) The patients must meet western medicine diagnostic criteria for acute gouty arthritis; (3) The patients must meet that integral syndrome differentiation conforms to the spleen beset by dampness syndrome and local syndrome differentiation conforms to blockage disease due to heat.

Exclusion criteria

Exclusion criteria: (1) Secondary hyperuricemia, such as cancer and perichemotherapy of leukemia, renal failure, cirrhosis of the liver and drug effect (such as diuretics, aspirin, antitubercular agents), et al.; (2) Acute infectious diseases, stroke, acute myocardial infarction, as well as other acute diseases and tumors, rheumatoid arthritis; (3) Patients with peptic ulcer and gastrointestinal bleeding.

Design outcomes

Primary

MeasureTime frame
According to the joint red and swollen, joint pain, and restricted movement;The gout relief index;Compare scores of syndrome before and after treatment;

Secondary

MeasureTime frame
Recurrence rate;Rrecurrence time;The dosage of colchicine of two groups in observation period;The blood uric acid, white blood cell count and erythrocyte sedimentation rate;

Countries

China

Contacts

Public ContactWang Shidong
wsd3122@sina.cn+86 13910965659

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026